Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:GHNASDAQ:OPCHNASDAQ:RDNTNASDAQ:SGRY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeGHGuardant Health$49.14-2.8%$44.45$20.14▼$52.92$6.27B1.372.14 million shs2.16 million shsOPCHOption Care Health$31.53-0.1%$32.08$21.39▼$35.53$5.17B0.741.88 million shs3.14 million shsRDNTRadNet$55.23-3.3%$55.43$45.00▼$93.65$4.29B1.43688,661 shs841,296 shsSGRYSurgery Partners$19.30-2.7%$22.36$18.87▼$33.97$2.54B1.931.17 million shs4.54 million shs7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceGHGuardant Health0.00%+3.16%+26.52%+9.70%+68.90%OPCHOption Care Health0.00%-0.97%-4.57%-8.73%+13.12%RDNTRadNet0.00%+0.95%-5.05%+15.98%-2.07%SGRYSurgery Partners0.00%-14.16%-14.53%-18.09%-20.84%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationGHGuardant Health3.671 of 5 stars2.53.00.04.31.52.50.6OPCHOption Care Health3.8474 of 5 stars2.43.00.04.23.61.70.6RDNTRadNet3.4339 of 5 stars2.82.00.04.61.52.50.0SGRYSurgery Partners2.4913 of 5 stars3.42.00.00.01.10.02.5Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceGHGuardant Health 3.00Buy$53.769.41% UpsideOPCHOption Care Health 2.88Moderate Buy$35.5012.59% UpsideRDNTRadNet 3.50Strong Buy$69.6026.02% UpsideSGRYSurgery Partners 2.70Moderate Buy$33.5673.86% UpsideCurrent Analyst Ratings BreakdownLatest SGRY, GH, OPCH, and RDNT Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/18/2025OPCHOption Care HealthJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Outperform ➝ Market Outperform$36.006/13/2025GHGuardant HealthMizuhoSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$60.00 ➝ $65.006/13/2025RDNTRadNetB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy ➝ Buy$69.006/12/2025RDNTRadNetB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeBuy ➝ Strong-Buy5/27/2025SGRYSurgery PartnersBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$25.00 ➝ $24.005/6/2025GHGuardant HealthPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$50.00 ➝ $60.005/5/2025GHGuardant HealthScotiabankSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform5/5/2025GHGuardant HealthScotiabankSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetSector Outperform ➝ Sector Outperform$52.00 ➝ $57.005/1/2025GHGuardant HealthCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$60.00 ➝ $65.005/1/2025GHGuardant HealthTD SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$56.00 ➝ $60.005/1/2025GHGuardant HealthBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$55.00 ➝ $60.00(Data available from 6/20/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookGHGuardant Health$739.02M8.24N/AN/A($1.13) per share-43.49OPCHOption Care Health$5.00B1.03$1.64 per share19.18$8.25 per share3.82RDNTRadNet$1.83B2.26$3.37 per share16.40$15.31 per share3.61SGRYSurgery Partners$3.11B0.79$1.82 per share10.59$25.15 per share0.77Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateGHGuardant Health-$436.37M-$3.39N/AN/AN/A-53.82%-1,200.44%-26.77%8/6/2025 (Estimated)OPCHOption Care Health$211.82M$1.2425.4325.021.914.12%16.90%7.00%7/30/2025 (Estimated)RDNTRadNet$2.79M-$0.43N/A104.21N/A-1.73%1.41%0.48%8/6/2025 (Estimated)SGRYSurgery Partners-$168.10M-$1.53N/A23.83N/A-6.10%2.41%0.99%8/5/2025 (Estimated)Latest SGRY, GH, OPCH, and RDNT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/12/2025Q1 2025SGRYSurgery Partners$0.08$0.04-$0.04-$0.30$777.77 million$776.00 million4/30/2025Q1 2025GHGuardant Health-$0.57-$0.49+$0.08-$0.77$189.91 million$203.47 million4/29/2025Q1 2025OPCHOption Care Health$0.36$0.40+$0.04$0.28$1.26 billion$1.33 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthGHGuardant HealthN/AN/AN/AN/AN/AOPCHOption Care HealthN/AN/AN/AN/AN/ARDNTRadNetN/AN/AN/AN/AN/ASGRYSurgery PartnersN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioGHGuardant HealthN/A4.113.76OPCHOption Care Health0.821.541.02RDNTRadNet0.872.012.01SGRYSurgery Partners1.091.891.73Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipGHGuardant Health92.60%OPCHOption Care Health98.05%RDNTRadNet77.90%SGRYSurgery PartnersN/AInsider OwnershipCompanyInsider OwnershipGHGuardant Health6.10%OPCHOption Care Health0.64%RDNTRadNet5.60%SGRYSurgery Partners2.30%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableGHGuardant Health2,021123.89 million116.33 millionNot OptionableOPCHOption Care Health8,088163.75 million162.70 millionOptionableRDNTRadNet11,02175.03 million70.83 millionOptionableSGRYSurgery Partners15,000128.16 million125.21 millionOptionableSGRY, GH, OPCH, and RDNT HeadlinesRecent News About These CompaniesSurgery Partners (NASDAQ:SGRY) Reaches New 1-Year Low - Here's WhyJune 20 at 1:19 PM | marketbeat.comSurgery Partners Sees Unusually High Options Volume (NASDAQ:SGRY)June 20 at 12:27 PM | marketbeat.comRSI Alert: Surgery Partners (SGRY) Now OversoldJune 19 at 1:58 AM | nasdaq.comSurgery Partners: The Plunge Doesn't Justify An UpgradeJune 18 at 8:57 PM | seekingalpha.comSurgery Partners stock falls after concluding discussions with Bain CapitalJune 18 at 1:54 AM | investing.comSurgery Partners rejects Bain Capital's acquisition offer, opts to remain publicJune 18 at 1:54 AM | bizjournals.comSURGERY PARTNERS, INC. and Bain Capital Conclude DiscussionsJune 18 at 1:54 AM | finance.yahoo.comSurgery Partners declines Bain Capital bid, stays publicly listed companyJune 18 at 1:54 AM | msn.comStock Movers: JetBlue, Solar Sector, Surgery PartnersJune 18 at 1:54 AM | bloomberg.comSurgery Partners Stock Slumps 13% After Company Rejects Bain Capital’s Take-Private ProposalJune 18 at 1:54 AM | msn.comSurgery Partners rejects Bain Capital's takeover proposalJune 18 at 1:54 AM | msn.comSurgery Partners (NASDAQ:SGRY) Shares Gap Down - Here's What HappenedJune 17 at 12:18 PM | marketbeat.comSurgery Partners Rejects Bain Capital's Private Buyout Offer, Will Remain IndependentJune 17 at 9:47 AM | benzinga.comSurgery Partners rejects Bain Capital's take-private offerJune 17 at 9:21 AM | reuters.comSurgery Partners Decides to Remain IndependentJune 17 at 8:41 AM | tipranks.comAnalysts Set Surgery Partners, Inc. (NASDAQ:SGRY) Price Target at $33.56June 10, 2025 | americanbankingnews.comTwo Sigma Investments LP Boosts Holdings in Surgery Partners, Inc. (NASDAQ:SGRY)June 7, 2025 | marketbeat.comSurgery Partners, Inc. (NASDAQ:SGRY) Receives Consensus Recommendation of "Moderate Buy" from AnalystsJune 7, 2025 | marketbeat.comE. Ohman J or Asset Management AB Sells 157,152 Shares of Surgery Partners, Inc. (NASDAQ:SGRY)June 6, 2025 | marketbeat.comSGRY Q1 Earnings Call: Volume Growth and Business Mix Shape Outlook Amid Margin PressuresJune 4, 2025 | finance.yahoo.comAmeriprise Financial Inc. Lowers Position in Surgery Partners, Inc. (NASDAQ:SGRY)June 4, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesIntel’s Turnaround May Be the Best Bet No One’s WatchingBy Jeffrey Neal Johnson | May 30, 2025View Intel’s Turnaround May Be the Best Bet No One’s WatchingBullish NVIDIA Market Set to Surge 50% Ahead of Q1 EarningsBy Thomas Hughes | May 27, 2025View Bullish NVIDIA Market Set to Surge 50% Ahead of Q1 EarningsAmong the Market’s Most Shorted: 2 Firms With +40% Short InterestBy Leo Miller | June 3, 2025View Among the Market’s Most Shorted: 2 Firms With +40% Short InterestWhy Super Micro Computer's Upside Could Trigger a Short SqueezeBy Gabriel Osorio-Mazilli | June 3, 2025View Why Super Micro Computer's Upside Could Trigger a Short SqueezeSuper Micro Computer Stock Clears New Path Higher on Saudi OrdersBy Gabriel Osorio-Mazilli | May 22, 2025View Super Micro Computer Stock Clears New Path Higher on Saudi OrdersSGRY, GH, OPCH, and RDNT Company DescriptionsGuardant Health NASDAQ:GH$49.14 -1.43 (-2.83%) Closing price 04:00 PM EasternExtended Trading$49.68 +0.53 (+1.09%) As of 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research. The company was incorporated in 2011 and is headquartered in Palo Alto, California.Option Care Health NASDAQ:OPCH$31.53 -0.03 (-0.10%) Closing price 04:00 PM EasternExtended Trading$31.53 0.00 (0.00%) As of 06:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.RadNet NASDAQ:RDNT$55.23 -1.89 (-3.31%) Closing price 04:00 PM EasternExtended Trading$55.24 +0.01 (+0.01%) As of 06:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; offers picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of breast, lung, and prostate images, as well as AI solutions for prostate cancer screening. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.Surgery Partners NASDAQ:SGRY$19.30 -0.53 (-2.67%) Closing price 04:00 PM EasternExtended Trading$19.45 +0.15 (+0.77%) As of 07:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers diagnostic imaging, laboratory, obstetrics, oncology, pharmacy, physical therapy, and wound care; and ancillary services, including multi-specialty physician practices, urgent care facilities, and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas New All-Time Highs Coming for Broadcom? Wall Street Says Yes Super Micro Computer Stock's Rally Backed by Strong Financials Forget the Fed: Home Depot Is the Real Gauge of the U.S. Consumer 3 Reasons AMD Could Be the Hottest Stock of the Summer Analysts Keep Boosting Taiwan Semiconductor Stock—Here's Why Robinhood Director Sells Millions, But HOOD Stock Eyes Gains Coinbase Stock Pops as Senate Passes GENIUS Stablecoin Bill Overheated Market? Analysts Watch These Red Flags Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
